Financial & Legal - SeniorCenters.com

Financial & Legal

Financial & Legal
Cardiovascular / Cardiology News From Medical News Today
Latest Cardiovascular / Cardiology News From Medical News Today.
Exercise Could Be The Heart's Fountain Of Youth Absence may make the heart grow fonder, but endurance exercise seems to make it younger. According to a study conducted at Washington University School of Medicine in St. Louis, older people who did endurance exercise training for about a year ended up with metabolically much younger hearts. The researchers also showed that by one metabolic measure, women benefited more than men from the training. Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol To FDA For Comment Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) ("Duska") announced that it has submitted for comment a synopsis of a proposed Phase 3 clinical study for its lead drug, ATPace(TM), to the U.S. Food and Drug Administration's (the "FDA") Division of Cardiovascular and Renal Products. FluoroPharma Announces Positive Phase I Safety Results For BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer For Positron Emission Tomography (PET) FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging. BFPET is FluoroPharma's second cardiovascular product to complete Phase I clinical development. BFPET is a PET imaging agent, designed to assess the blood flow in the heart (myocardial perfusion). Study Reveals Potential For NT-proBNP As A Marker To Predict Cardiovascular Risks From Anti-Inflammatory Drugs A Roche Diagnostics-sponsored pilot study evaluating the use of N-terminal pro-B-type natriuretic peptide (NT-proBNP) confirms the potential value of NT-proBNP for risk stratification in predicting the risk of cardiovascular adverse events (CV-AE) in patients treated with non-steroidal anti-inflammatory drugs of the COX inhibitor class. The complete results of the study, currently available at UK Sugar Study Is Sweetener For Stem Cell Science Scientists at The University of Manchester are striving to discover how the body's natural sugars can be used to create stem cell treatments for heart disease and nerve damage - thanks to a 370,000 pound funding boost. All cells that make up the tissues of the body - such as skin, liver, brain and blood - are surrounded by a layer of sugars that coat the cells. Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format Interleukin Genetics, Inc. (Amex: ILI), announced the launch of an enhanced test report format and information package for the company's Heart Health Genetic Test. The test is currently marketed under the brand name Gensona(R) Heart Health Genetic Test by Quixtar/Amway. The new report will include quantified risk information on heart attack and coronary artery disease generated from clinical studies and conducted by the company. Amarin Proceeding To Phase 3 With AMR101 For Hypertriglyceridemia Amarin Corporation plc (NASDAQ: AMRN) announced that the Company recently met with officials at the U.S. Food and Drug Administration (FDA) to discuss the Company's plans to develop AMR101 for the treatment of hypertriglyceridemia. Following these discussions, the Company is proceeding to Phase 3 with AMR101 in hypertriglyceridemia. Dr. Heart Disease Is Linked To Worse Mental Processes That, In Turn, Predict The Onset Of Dementia Coronary heart disease is associated with a worse performance in mental processes such as reasoning, vocabulary and verbal fluency, according to a study of 5837 middle-aged Whitehall civil servants. The study also found that the longer ago the heart disease had been diagnosed, the worse was the person's cognitive performance and this effect was particularly marked in men. Study Finds Link Between Small Birth Size And Changes To The Cardiovascular System That Predispose To Disease In Later Life Researchers have found the first evidence that smaller size at birth is associated with specific alterations in the functioning of the heart and circulation in children and that these changes differ between boys and girls. Cincinnati Sub-Zero Medical And The Sudden Cardiac Arrest Association Unite To Address Cardiac Arrest Cincinnati Sub-Zero (CSZ) Medical, a division of CSZ Products, Inc. and the leader in the design and development of advanced patient temperature management solutions, today announced its collaborative partnership with the Sudden Cardiac Arrest Association (SCAA). The SCAA is dedicated to preventing the loss of life from sudden cardiac arrest.